HEDS have authored three new reports for the National Institute for Health Research.
NIHR |
STA:
Sodium Zirconium Cyclosilicate for Hyperkalaemia: A Single Technology Appraisal September 2018
Highly Specialised Technologies:
Patisiran for treating hereditary transthyretin-related amyloidosis: A Highly Specialised Technology Appraisal - October 2018
Health Technology Assessment - TARs:
Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews - December 2018